Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy Journal Article


Authors: Ganzel, C.; Devlin, S.; Douer, D.; Rowe, J. M.; Stein, E. M.; Tallman, M. S.
Article Title: Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy
Abstract: Very little is known about secondary acute lymphoblastic leukaemia (s-ALL). This retrospective analysis studied a cohort of s-ALL patients treated at a single centre between 1994 and 2013, while comparing therapy-associated ALL (t-ALL) and antecedent malignancy ALL (am-ALL) patients. Thirty-two patients with s-ALL were identified. The overall incidence was 9·4% among ALL adults while T-cell s-ALL was rare (12% of s-ALLs). The median time interval between two malignant diagnoses was 5·3 years (range: 0·1-28). In contrast to previous reports, most of the s-ALLs were CD10 + and without KMT2A (MLL) abnormalities. The overall survival (OS) rates of the entire cohort at 12 and 24 months from ALL diagnosis was 49% and 25%, respectively. Most patients (n = 23, 72%) received prior chemo-/radio-therapy for their first malignancy (t-ALL) and only 9 (28%) did not (am-ALL). No significant difference was found in the incidence of B-/T- lineage ALL, extramedullary disease, blood count, and the rate of Philadelphia-positive ALL, nor in the rates of complete remission (P = 0·55) and OS (P = 0·97). This similarity, together with high incidence of family malignancy in both groups, raise the possibility that s-ALL patients may have an inherent predisposition to malignancies and a history of previous therapy may be of lesser importance in the pathogenesis of s-ALL. © 2015 John Wiley & Sons Ltd.
Keywords: therapy; acute lymphoblastic leukaemia; acute leukaemia; secondary acute lymphoblastic leukaemia; therapy related acute lymphoblastic leukaemia
Journal Title: British Journal of Haematology
Volume: 170
Issue: 1
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2015-07-01
Start Page: 50
End Page: 55
Language: English
DOI: 10.1111/bjh.13386
PROVIDER: scopus
PUBMED: 25823602
DOI/URL:
Notes: Export Date: 2 July 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Martin Stuart Tallman
    649 Tallman
  3. Dan Douer
    87 Douer
  4. Sean McCarthy Devlin
    601 Devlin
  5. Chezi Yeehezkel Ganzel
    7 Ganzel